Test Price
2,800 AED✅ Home Collection Available
CDT1 Gene Meier‑Gorlin Syndrome Type 4 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Diagnostic Precision: 99.9% sensitivity via ISO‑validated next‑generation sequencing. Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily 8 AM–11 PM across Dubai Healthcare City and beyond. Post‑Test Guidance: Complimentary telephonic consultation with a DHA‑licensed genetic counsellor. Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CDT1 gene test uses next‑generation sequencing (NGS) to detect pathogenic variants in the CDT1 gene, confirming Meier‑Gorlin syndrome type 4. This rare autosomal recessive disorder is characterised by short stature, microtia, and patellar aplasia or hypoplasia. Our whole‑gene analysis includes copy‑number variant (CNV) calling, ensuring comprehensive detection of deletions, duplications, and single‑nucleotide variants.
| Feature | Our Test (Trusted UAE Lab) | Closest Alternative |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; full‑gene NGS with copy‑number analysis | Single‑gene Sanger sequencing; limited detection of large deletions/duplications |
| Method | Next‑Generation Sequencing (NGS) – ISO 9001:2015 validated | Sanger sequencing or gene‑panel without CNV calling |
| Turnaround Time | 3 – 4 weeks (expedited options available) | 4 – 6 weeks |
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I recognise the emotional weight of a rare disease diagnosis. The CDT1 NGS test provides definitive clarity, enabling tailored clinical management and informed family planning. Our laboratory adheres to the highest international standards, ensuring parents receive accurate, actionable results.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID 9294403
Advisory: Pre‑Test Considerations
Do not discontinue any prescribed medication or alter a treatment plan without explicit consultation with your treating physician. This test is for diagnostic confirmation only and should not be used as a sole basis for therapeutic decisions.
Safety Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Active systemic infection compromising DNA integrity; inability to collect adequate whole blood (1–2 mL) or FTA card sample; lack of informed consent (guardian consent for minors).
- Emergency Red Flags: Infant with severe failure to thrive, sudden respiratory distress, cyanosis, or signs of metabolic crisis — seek immediate hospital emergency care.
Patient FAQ & Clinical Guidance
1. What is the CDT1 gene test for Meier‑Gorlin syndrome type 4?
The CDT1 gene test identifies pathogenic variants in the CDT1 gene, confirming a diagnosis of Meier‑Gorlin syndrome type 4. It analyses the entire coding region using NGS, ensuring detection of single‑nucleotide changes, small indels, and copy‑number variants that cause the characteristic short stature, microtia, and patellar aplasia/hypoplasia.
2. How is the sample collected, and is it painful for my child?
Sample collection requires only a small blood draw (1–2 mL) or a painless finger‑prick drop on an FTA card. Our pediatric phlebotomists use child‑friendly techniques, and we offer VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
3. When will I receive the results, and who will explain them?
Results are delivered within 3 to 4 weeks via a secure online portal, followed by a telephonic post‑clinical guidance session with a DHA‑licensed genetic counsellor who interprets the report, discusses implications, and coordinates any needed referrals.
UAE Regulatory & Data Privacy Adherence
This testing service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. DHA Facility License No. 1143. Laboratory processing is performed in an ISO 9001:2015 certified facility under DHA‑approved protocols. Patient data is encrypted and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | CDT1 Gene Meier‑Gorlin Syndrome Type 4 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Whole blood (EDTA, 1–2 mL) or FTA card; extracted DNA also accepted |
| Methodology Used | Next‑Generation Sequencing (NGS) with CNV calling, ISO 9001:2015 validated |
| ICD-10-CM Code | Q87.1 |
| LOINC Code | 81225-0 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians